JPMorgan Asset Management's Alexander Treves said investors should watch India's plan to vaccinate its population for the near-term outlook for stocks.
India's BSE Sensex on Thursday briefly soared to a record high, crossing the 50,000 level for the first-time ever.A pedestrian speaks on a mobile phone as he looks at share prices on a digital broadcast outside the Bombay Stock Exchange in Mumbai on November 10, 2020.SINGAPORE — A major Indian stock market hit a record high last week — and analysts say the share valuations are looking fair at the moment, though developments on the vaccine front could affect the near-term outlook.
India's BSE Sensex on Thursday soared to a record high, crossing the 50,000 level for the first-time before shedding those gains. "Indian equities are already quite fully priced," according Alexander Treves, investment specialist for emerging markets and Asia-Pacific equities at JPMorgan Asset Management.
He pointed out that "the near-term outlook for India depends to some extent on India's success in rolling out a vaccine for COVID," and added that the market is already factoring in "some good news" on this front.
Hedge Funds are DUMPING Tech Stocks! 😳😧 Institutional DATA Uncovered! ⬇️⬇️
AMD Price after the earning call manipulated? Perfect time and company not a FAANG but large enough, Bullish market, knowing earnings being beat, Huge call options?
Is this A intimidating photo. Listen i watched few Bollywood movies. We cool. Mvg 🔵🔴🔵🔴🌍✅
good luck